<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0015">
 <label>Table 49.2</label>
 <caption>
  <p>Bone marrow pathologies associated with human viral infections.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Pathology</th>
    <th>Virus</th>
    <th>Comments</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="2">Pancytopenia</td>
    <td>EBV</td>
    <td>Self-resolving</td>
   </tr>
   <tr>
    <td>HCV</td>
    <td>Affected by medication</td>
   </tr>
   <tr>
    <td rowspan="3">Aplastic anemia</td>
    <td>Parvovirus B19</td>
    <td>Driven by infection of erythroid progenitors</td>
   </tr>
   <tr>
    <td>EBV, CMV, VZV, HHV, HIV, HAV, and HCV</td>
    <td>Driven by a strong antiviral T cell response and ensuing cytokine production</td>
   </tr>
   <tr>
    <td>Dengue</td>
    <td>Mechanism unknown</td>
   </tr>
   <tr>
    <td rowspan="5">HLH</td>
    <td>CMV</td>
    <td rowspan="5">Driven by the ensuing antiviral immune response rather than the virus itself</td>
   </tr>
   <tr>
    <td>Parvovirus B19</td>
   </tr>
   <tr>
    <td>Dengue</td>
   </tr>
   <tr>
    <td>HAV</td>
   </tr>
   <tr>
    <td>HIV (acute)</td>
   </tr>
   <tr>
    <td rowspan="2">Lymphoproliferative disorders and malignancies</td>
    <td>EBV</td>
    <td>Infectious mononucleosis and chronic active EBV disease</td>
   </tr>
   <tr>
    <td>HCV</td>
    <td>Acute myeloid leukemia, primary myelodysplastic syndrome</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Table reproduced from Pascutti MF, Erkelens MN, Nolte MA. Impact of viral infections on hematopoiesis: from beneficial to detrimental effects on Bone marrow output. Front Immunol 2016;7:364. Reprinted under 
    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/" id="interref7" xmlns:xlink="http://www.w3.org/1999/xlink">https://creativecommons.org/licenses/by/4.0/</ext-link>.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
